ARCHIVES

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

This article is from The Cancer Letter archive.

Vol. 03 No. 48 | December 2, 1977

Download PDF Visit The Full Archive

Related Articles

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

Waksal Pleads Guilty To Securities Fraud

October 18, 2002

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011